Pricing Log in Create free account

Artelo Biosciences, Inc. (ARTL) vs Trevena, Inc. (TRVN)

Artelo Biosciences, Inc. and Trevena, Inc. are both Biotechnology companies. Trevena, Inc. is the larger, with a market value of $1.8M against $1.5M — 1.2× the size. Artelo Biosciences, Inc. has the higher net margin (0.00% vs −6,233.7%) and the lower return on invested capital (−865.9% vs 0.00%). Across the 13 metrics below, Trevena, Inc. leads on 7 and Artelo Biosciences, Inc. on 6.

Valuation

Metric ARTL TRVN Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 0.16 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.31 n/m 0.64
EV/Sales n/m 35.04 9.21
Earnings yield (4,348.52%) 0.00% (33.15%)
Free cash flow yield (1,553.13%) 0.00% (25.50%)

Profitability

Metric ARTL TRVN Biotechnology median
Gross margin 0.00% (190.29%) 65.16%
Operating margin 0.00% (5,879.85%) 0.00%
Net margin 0.00% (6,233.70%) 0.00%
Free cash flow margin 0.00% (4,961.72%) 0.00%
Return on equity (705.71%) 344.49% (56.36%)
Return on assets (234.30%) (105.83%) (48.04%)
Return on invested capital (865.85%) 0.00% 0.00%

Growth

Metric ARTL TRVN Biotechnology median
Revenue growth (TTM) — (82.97%) 6.02%
EPS growth (last fiscal year) 31.57% 58.37% 30.26%
Revenue growth, 5-year CAGR — (11.43%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARTL TRVN Biotechnology median
Debt to equity 0.00 (1.41) 0.00
Current ratio 3.00 2.42 4.72
Net debt to EBITDA 0.05 0.06 0.96

Dividend

Metric ARTL TRVN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ARTL TRVN Biotechnology median
Market cap 1.50m 1.81m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack